Scribd Logo
Upload

Welcome to Scribd!

  • 134 views

    Multi Product Bulk Drug

    Uploaded by

    Murali Mohan
    The document proposes a multi-product bulk drug manufacturing project with an initial capacity of 300 tons per year. It recommends selecting products that have recently come off patent or will come off patent in 2007 from markets in developed countries and India. A location in the declared chemical zone near Vizag, India is suggested. The project cost is estimated to be between 15 to 20 crores with a turnover potential of 50 to 60 crores per year. Apitco's consultancy services include product mix selection, technology tie-ups, and project planning.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd

    Multi Product Bulk Drug

    Uploaded by

    Murali Mohan
    134 views5 pages
    The document proposes a multi-product bulk drug manufacturing project with an initial capacity of 300 tons per year. It recommends selecting products that have recently come off patent or will come off patent in 2007 from markets in developed countries and India. A location in the declared chemical zone near Vizag, India is suggested. The project cost is estimated to be between 15 to 20 crores with a turnover potential of 50 to 60 crores per year. Apitco's consultancy services include product mix selection, technology tie-ups, and project planning.

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The document proposes a multi-product bulk drug manufacturing project with an initial capacity of 300 tons per year. It recommends selecting products that have recently come off patent or will come off patent in 2007 from markets in developed countries and India. A location in the declared chemical zone near Vizag, India is suggested. The project cost is estimated to be between 15 to 20 crores with a turnover potential of 50 to 60 crores per year. Apitco's consultancy services include product mix selection, technology tie-ups, and project planning.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    134 views5 pages

    Multi Product Bulk Drug

    Uploaded by

    Murali Mohan
    The document proposes a multi-product bulk drug manufacturing project with an initial capacity of 300 tons per year. It recommends selecting products that have recently come off patent or will come off patent in 2007 from markets in developed countries and India. A location in the declared chemical zone near Vizag, India is suggested. The project cost is estimated to be between 15 to 20 crores with a turnover potential of 50 to 60 crores per year. Apitco's consultancy services include product mix selection, technology tie-ups, and project planning.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 5

    MULTI PRODUCT BULK DRUG (API) PROJECT

    At present the global Pharma market is estimated at US$ 500 billion. The market is expected to continue to grow at the rate of 5 to 6% per year. During the last decade India has built up strong position as a bulk drug (Active Pharmaceutical Ingredients API) supplier to the international market and expects to further consolidate the position. For this reasons many new entrepreneurs are considering entering this industry. New aspirants will have to consider following aspects at the time of making the investment decision WTO regime that came into effect from 2005 provides for product Patent protection. Environmental protection rules are stringent now CGMP (current good manufacturing practices) requirements are to be met. In effect there are entry barriers for small units. However a well planned medium size unit is still an attractive investment proposition Proposal: A grass root project in a declared chemical zone, having environmental clearances is a profitable proposition. The plant should be constructed to meet environmental and GMP requirements Product mix A number of APIs have come off patent are about to come off patent during 2007. (List at Annexure). The new project can be planned with one or two of these products along with one two older products. Suggested product mix Drug Brand name Used for treatment of Acidity / heart burn allergies Insomnia Asthma Diuretic Infections Arthritis Suggested manufacturing capacity 30 TPA 30 TPA 15 TPA 15 TPA 30 TPA 60 TPA 300 TPA

    Lansprazole / Rabeprazole Ceterizine / Fexofenadine Zolopidem Fluticasone Torosemide Hydrochlorothiazide Sparfloxacin Diclofenac / Aceclofenac

    Prevacid / aciphex Zyrtec / Allegra Ambien Advair /

    Market Top selling therapeutic groups in developed countries and in India are shown below. It would be advisable to select two products aimed at export market (developed countries) and two products for Indian market. Developed countries Cardiovascular Anti-ulcerants Anti-depressants Anti-infective India Anti-infective Anti-rheumatic vitamins Anti- ulcerants

    It should be understood that the market will remain highly competitive. Marketing tieups and contract manufacturing up to 50 % capacity can reduce the risk.

    Manufacturing process The manufacturing process of bulk drugs consists of chemical synthesis extending to seven eight stages of processing involving different type of chemical reactions. Technology Technology for manufacturing of the product listed under product mix are available from private consultants. Some times the technology is available on lab scale. In such cases the process has to be scaled up. Choosing one or two proven technologies and one or two technologies under development will be cost effective.

    Plant and Machinery Plant and Machinery for bulk drug project consists of Glass lined, stainless steel reactors, heat exchangers, centrifuges, filters, dryers and tanks. The utility systems consist of boiler, chilling plants, and water purification systems. All the equipment is indigenously available.

    Raw materials Raw materials consist of various chemicals and solvents. Some of the raw materials have to be imported.

    Utilities Utilities required are, steam, Power and water. Project cost: Over all capacity of 300 Tons per annum is recommended (one lac liter reactor volume) spread among four products. The project cost would be Rs. 15 to 20 crores. Turnover and profitability: Turnover of Rs. 50 to 60 crores per annum can be obtained by judiciously choosing medium and high value products. Suggested location: Pharma city near Vizag Entrepreneur profile: Bulk drug manufacturing line is more suited to Technocrats, who can plan for development of new technologies. Alternately the entrepreneur should be able to develop a very good technical team. Apitcos consultancy: 1. Product mix selection based on market survey and technology availability. 2. Technology tie-up 3. Project planning.

    List of top selling drugs going off patent is given below.

    DRUG

    Treats

    Company

    Sales (billion) $8.4 $4.4 $4.4 $3.8 $3.6

    1 2 3 4 5

    LIPITOR ZOCOR NEXIUM PREVACID ADVAIR DISKUS PLAVIX

    High cholesterol High cholesterol Heartburn Heartburn Asthma

    Pfizer Merck AstraZeneca Abbott & Takeda GlaxoSmithKline

    Heart disease

    Bristol-Myers Sanofi-Aventis Pfizer Amgen

    Squibb

    &

    $3.5

    7 8 9 10 11 12 13 14 15 16 17 18 19

    ZOLOFT EPOGEN PROCRIT ARANESP ENBREL NORVASC SEROQUEL EFFEXOR XR ZYPREXA SINGULAIR PROTONIX RISPERDAL NEULASTA

    Depression Anemia Anemia Anemia Rheumatoid arthritis High blood pressure Schizophrenia Depression Schizophrenia Asthma & Allergies Heartburn Schizophrenia Chemotherapy effects side

    $3.1 $3.0 $3.0 $2.8 $2.7 $2.6 $2.6 $2.6 $2.5 $2.5 $2.4 $2.3 $2.2

    Johnson & Johnson Amgen Amgen & Wyeth Pfizer AstraZeneca Wyeth Eli Lilly Merck Wyeth Johnson & Johnson Amgen

    20

    REMICADE

    Rheumatoid arthritis

    Johnson & Johnson

    You might also like